These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37737898)

  • 1. The impact of intensified staging and combined therapies in locally advanced pancreatic cancer: a secondary analysis of prospective studies.
    Fiore M; Petrianni GM; Trecca P; D'Ercole G; Coppola A; La Vaccara V; Taralli S; Cimini P; Greco C; Ippolito E; Calcagni ML; Beomonte Zobel B; Caputo D; Coppola R; Ramella S; D'Angelillo RM
    Int J Surg; 2023 Sep; ():. PubMed ID: 37737898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yield of staging laparoscopy before treatment of locally advanced pancreatic cancer to detect occult metastases.
    Suker M; Koerkamp BG; Coene PP; van der Harst E; Bonsing BA; Vahrmeijer AL; Mieog JSD; Swijnenburg RJ; Dwarkasing RS; Roos D; van Eijck CHJ
    Eur J Surg Oncol; 2019 Oct; 45(10):1906-1911. PubMed ID: 31186205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction gemcitabine and oxaliplatin therapy followed by a twice-weekly infusion of gemcitabine and concurrent external-beam radiation for neoadjuvant treatment of locally advanced pancreatic cancer: a single institutional experience.
    Leone F; Gatti M; Massucco P; Colombi F; Sperti E; Campanella D; Regge D; Gabriele P; Capussotti L; Aglietta M
    Cancer; 2013 Jan; 119(2):277-84. PubMed ID: 22778019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOLFIRINOX and radiotherapy for locally advanced pancreatic cancer: A cohort study.
    Suker M; Nuyttens JJ; Groot Koerkamp B; Eskens FALM; van Eijck CHJ
    J Surg Oncol; 2018 Nov; 118(6):1021-1026. PubMed ID: 30259526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of volume-based FDG PET/CT parameters in patients with locally advanced pancreatic cancer treated with chemoradiation therapy.
    Choi HJ; Lee JW; Kang B; Song SY; Lee JD; Lee JH
    Yonsei Med J; 2014 Nov; 55(6):1498-506. PubMed ID: 25323885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients.
    Mattiucci GC; Boldrini L; Nardangeli A; D'Aviero A; Buwenge M; Cellini F; Deodato F; Dinapoli N; Frascino V; Macchia G; Morganti AG; Valentini V
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):661-667. PubMed ID: 33001271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longer Course of Induction Chemotherapy Followed by Chemoradiation Favors Better Survival Outcomes for Patients With Locally Advanced Pancreatic Cancer.
    Faisal F; Tsai HL; Blackford A; Olino K; Xia C; De Jesus-Acosta A; Le DT; Cosgrove D; Azad N; Rasheed Z; Diaz LA; Donehower R; Laheru D; Hruban RH; Fishman EK; Edil BH; Schulick R; Wolfgang C; Herman J; Zheng L
    Am J Clin Oncol; 2016 Feb; 39(1):18-26. PubMed ID: 24351782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer.
    Stein SM; James ES; Deng Y; Cong X; Kortmansky JS; Li J; Staugaard C; Indukala D; Boustani AM; Patel V; Cha CH; Salem RR; Chang B; Hochster HS; Lacy J
    Br J Cancer; 2016 Mar; 114(7):737-43. PubMed ID: 27022826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Survival Benefit of Chemoradiotherapy following Induction Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Unresectable Locally Advanced Pancreatic Cancer.
    Takada R; Ikezawa K; Daiku K; Maeda S; Abe Y; Urabe M; Kai Y; Yamai T; Fukutake N; Nakabori T; Uehara H; Ashida R; Akita H; Takahashi H; Teshima T; Ohkawa K
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent chemoradiotherapy with or without induction chemotherapy versus chemotherapy alone in patients with locally advanced pancreatic cancer.
    Huang WK; Kuo YC; Tsang NM; Hsu HC; Shen WC; Chou WC; Yang TS; Chen JS
    Anticancer Res; 2014 Nov; 34(11):6755-61. PubMed ID: 25368287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage chemoradiotherapy after primary chemotherapy for locally advanced pancreatic cancer: a single-institution retrospective analysis.
    Mayahara H; Ito Y; Morizane C; Ueno H; Okusaka T; Kondo S; Murakami N; Morota M; Sumi M; Itami J
    BMC Cancer; 2012 Dec; 12():609. PubMed ID: 23256481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of gross tumor volume delineated by FDG-PET-CT based radiotherapy treatment planning in patients with locally advanced pancreatic cancer treated with chemoradiotherapy.
    Parlak C; Topkan E; Onal C; Reyhan M; Selek U
    Radiat Oncol; 2012 Mar; 7():37. PubMed ID: 22429939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiation in patients with borderline resectable or unresectable locally advanced pancreatic cancer.
    Esnaola NF; Chaudhary UB; O'Brien P; Garrett-Mayer E; Camp ER; Thomas MB; Cole DJ; Montero AJ; Hoffman BJ; Romagnuolo J; Orwat KP; Marshall DT
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):837-44. PubMed ID: 24606850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy of perioperative chemoradiotherapy on esophageal squamous cell carcinoma.
    Lv J; Cao XF; Zhu B; Ji L; Tao L; Wang DD
    World J Gastroenterol; 2010 Apr; 16(13):1649-54. PubMed ID: 20355244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical usefulness of ¹⁸F-fluorodeoxyglucose-positron emission tomography in patients with locally advanced pancreatic cancer planned to undergo concurrent chemoradiation therapy.
    Chang JS; Choi SH; Lee Y; Kim KH; Park JY; Song SY; Cho A; Yun M; Lee JD; Seong J
    Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):126-33. PubMed ID: 25015206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The efficacy of radiotherapy based combined therapy for unresectable locally invasive bladder cancer and its associated factors analysis].
    Zhong SJ; Gao JJ; Tang P; Liu YP; Wang SL; Fang H; Qiu JP; Song YW; Chen B; Qi SN; Tang Y; Lu NN; Jing H; Zhai YR; Zhou AP; Bi XG; Ma JH; Li CL; Zhang Y; Shou JZ; Xing NZ; Li YX
    Zhonghua Zhong Liu Za Zhi; 2023 Feb; 45(2):175-181. PubMed ID: 36781240
    [No Abstract]   [Full Text] [Related]  

  • 17. A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma.
    Hosein PJ; Macintyre J; Kawamura C; Maldonado JC; Ernani V; Loaiza-Bonilla A; Narayanan G; Ribeiro A; Portelance L; Merchan JR; Levi JU; Rocha-Lima CM
    BMC Cancer; 2012 May; 12():199. PubMed ID: 22642850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma.
    Mellon EA; Hoffe SE; Springett GM; Frakes JM; Strom TJ; Hodul PJ; Malafa MP; Chuong MD; Shridhar R
    Acta Oncol; 2015 Jul; 54(7):979-85. PubMed ID: 25734581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival Benefit Associated With Resection of Locally Advanced Pancreatic Cancer After Upfront FOLFIRINOX Versus FOLFIRINOX Only: Multicenter Propensity Score-matched Analysis.
    Brada LJH; Daamen LA; Magermans LG; Walma MS; Latifi D; van Dam RM; de Hingh IH; Liem MSL; de Meijer VE; Patijn GA; Festen S; Stommel MWJ; Bosscha K; Polée MB; Nio YC; Wessels FJ; de Vries JJJ; van Lienden KP; Bruijnen RC; Busch OR; Koerkamp BG; van Eijck C; Molenaar QI; Wilmink HJW; van Santvoort HC; Besselink MG;
    Ann Surg; 2021 Nov; 274(5):729-735. PubMed ID: 34334641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of induction chemotherapy with gemcitabine plus 5-fluorouracil followed by gemcitabine-based concurrent chemoradiotherapy for unresectable locally advanced pancreatic cancer.
    Kurt E; Kurt M; Kanat O; Cetintas SK; Aygun S; Palazoglu T; Ozkan L; Evrensel T; Kaya E; Manavoglu O
    Tumori; 2006; 92(6):481-6. PubMed ID: 17260487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.